Introduction Most studies describing the natural history and prognostic factors for malignant
pleural mesothelioma antedate accurate pathologic diagnosis, staging by computed …

Objective: Treatment of malignant pleural mesothelioma (MPM) remains disappointing,
although recent reports suggest that multimodality therapy including surgery may provide a …

Introduction: This study characterizes the overall survival (OS) and variables affecting OS in
patients with malignant pleural mesothelioma. Methods: A total of 9701 patients with …

Background: Surgery with pleurectomy/decortication (P/D) or extrapleural pneumonectomy
(EPP) can be an option for selected patients with resectable malignant pleural …

Background Malignant pleural mesothelioma (MPM) remains an aggressive malignancy that
is difficult to cure. However, the treatment paradigm of MPM has evolved, and the national …

Malignant pleural mesothelioma (MPM) is a rare tumour but with increasing incidence and a
poor prognosis. In 2008, the European Respiratory Society/European Society of Thoracic …

Abstract Background and Objectives: Malignant pleural mesothelioma (MPM) is an asbestos-
related disease of the pleura with a survival time without treatment ranging from 4 to 12 …

BACKGROUND: Malignant pleural mesothelioma is a rare, aggressive, and deadly
malignancy. Despite increasing incidence, no treatment modality is accepted standard of …

Malignant pleural mesothelioma (MPM) is an uncommon disease most often associated with
occupational asbestos exposure and is steadily increasing in worldwide incidence. Patients …

Background The current staging system for malignant pleural mesothelioma (MPM) is
controversial. To plan revisions of this system, the International Association for the Study of …